Els Torreele - Concepedia

Author

Els Torreele

University College London ORCID

Also Known As

E Torreele, E. Torreele, Els Torreele, TORREELE E., Torreele, E, Torreele, E., Torreele, Els

139

Publications

4.8K

Citations

H-Index

111

Concepts

All Affiliations

University College London Drugs for Neglected Diseases Initiative Swiss Tropical and Public Health Institute Ghent University University of Oxford

About

Els Torreele is an author at University College London specializing in medicine, public health, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	1.3K
2	Engineering	3	3	106
3	Natural Sciences	2	2	206
4	Business	1	1	30
5	Nursing	1	1	19

Els Torreele

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial Gérardo Priotto, S Kasparian, Wilfried Mutombo, The Lancet Translational MedicineParasitic ProtozoaAfrican TrypanosomiasisPhase IiiImmunology	2009	528
Fexinidazole – A New Oral Nitroimidazole Drug Candidate Entering Clinical Development for the Treatment of Sleeping Sickness Els Torreele, Bernadette Bourdin Trunz, David Tweats, PLoS neglected tropical diseases	2010	311
COVID-19 vaccine efficacy and effectiveness—the elephant (not) in the room Piero Olliaro, Els Torreele, Michel Vaillant The Lancet Microbe ImmunologyCovid-19 EpidemiologyVaccine HesitancyCovid-19Vaccine Surveillance	2021	219
Fexinidazole: A Potential New Drug Candidate for Chagas Disease Maria Terezinha Bahia, Isabel Mayer de Andrade, Tassiane Assíria Fontes Martins, PLoS neglected tropical diseases	2012	179
Global framework on essential health R&D Pierre Chirac, Els Torreele The Lancet Global Health ProgramHealth PolicyGlobal HealthInternational HealthGlobal Healthcare	2006	166
Antitrypanosomal Activity of Fexinidazole, a New Oral Nitroimidazole Drug Candidate for Treatment of Sleeping Sickness Marcel Kaiser, Michael Bray, Monica Cal, Antimicrobial Agents and Chemotherapy Bioorganic ChemistryAntiparasitic AgentSleeping SicknessPharmacotherapyAntimicrobial Chemotherapy	2011	153
Determination of an Optimal Dosing Regimen for Fexinidazole, a Novel Oral Drug for the Treatment of Human African Trypanosomiasis: First-in-Human Studies Antoine Tarral, Séverine Blesson, Olaf Valverde Mordt, Clinical Pharmacokinetics	2014	96
Consultative meeting to develop a strategy for treatment of cutaneous leishmaniasis. Institute Pasteur, Paris. 13–15 June, 2006 Farrokh Modabber, Pierre Buffet, Els Torreele, Kinetoplastid Biology and Disease	2007	69
Novel 3-Nitro-1<i>H</i>-1,2,4-triazole-Based Aliphatic and Aromatic Amines as Anti-Chagasic Agents Maria V. Papadopoulou, Bernadette Bourdin Trunz, William D. Bloomer, Journal of Medicinal Chemistry	2011	53
1-Aryl-4-nitro-1H-imidazoles, a new promising series for the treatment of human African trypanosomiasis Bernadette Bourdin Trunz, Rafał G. Jędrysiak, David Tweats, European Journal of Medicinal Chemistry Medicinal ChemistryHuman African TrypanosomiasisBioorganic ChemistryBiochemistryNew Promising Series	2011	53

Page 1